The Chief Information Officer of the Novartis Institutes for BioMedical Research discusses his new role.

Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.

Doyle describes the road to improving patient outcomes across Europe through the HARMONY Alliance.

A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.

Low- and middle-income countries will account for some three in four of the world’s cancer deaths within the next decade without better access to care. It’s a gap Amy Israel and her team at Novartis are trying to bridge.

Cambridge neighbors, NIBR and Harvard, further disrupt technology. Read how their alliance is accelerating drug discovery.